A STABILITY-INDICATING HPLC METHOD FOR THE DETERMINATION OF POTENTIAL IMPURITIES IN A NEW FIXED DOSE COMBINATION OF DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS USED IN THE FIRST LINE TREATMENT OF HIV-1 INFECTION. Int. Res. J. Pharm. [Internet]. 2018 May 18 [cited 2026 Nov. 2];9(5):90-9. Available from: https://irjponline.org/index.php/irjp/article/view/1071